Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Free Cash Flow (2019 - 2025)

Outset Medical (OM) has disclosed Free Cash Flow for 7 consecutive years, with -$9.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 37.74% to -$9.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$47.1 million, a 59.49% increase, with the full-year FY2025 number at -$47.1 million, up 59.49% from a year prior.
  • Free Cash Flow was -$9.7 million for Q4 2025 at Outset Medical, down from -$6.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$5.1 million in Q2 2025 to a low of -$45.9 million in Q1 2024.
  • A 5-year average of -$28.7 million and a median of -$30.7 million in 2021 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: plummeted 51.58% in 2021, then skyrocketed 84.69% in 2025.
  • Outset Medical's Free Cash Flow stood at -$35.6 million in 2021, then rose by 19.99% to -$28.5 million in 2022, then grew by 21.94% to -$22.2 million in 2023, then rose by 29.55% to -$15.6 million in 2024, then surged by 37.74% to -$9.7 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Free Cash Flow are -$9.7 million (Q4 2025), -$6.5 million (Q3 2025), and -$5.1 million (Q2 2025).